Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Nov 21, 2025, 4:00 PM EST

Silence Therapeutics Statistics

Total Valuation

SLNCF has a market cap or net worth of 298.05 million. The enterprise value is 196.04 million.

Market Cap298.05M
Enterprise Value 196.04M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 141.70M
Shares Outstanding n/a
Shares Change (YoY) +7.98%
Shares Change (QoQ) -1.39%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 24.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.54
PB Ratio 4.02
P/TBV Ratio 4.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.04
EV / Sales 7.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.70

Financial Position

The company has a current ratio of 7.69, with a Debt / Equity ratio of 0.00.

Current Ratio 7.69
Quick Ratio 7.16
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.00
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -64.30% and return on invested capital (ROIC) is -43.50%.

Return on Equity (ROE) -64.30%
Return on Assets (ROA) -23.40%
Return on Invested Capital (ROIC) -43.50%
Return on Capital Employed (ROCE) -54.08%
Revenue Per Employee 222,672
Profits Per Employee -556,379
Employee Count116
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, SLNCF has paid 335,000 in taxes.

Income Tax 335,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -70.91% in the last 52 weeks. The beta is 1.34, so SLNCF's price volatility has been higher than the market average.

Beta (5Y) 1.34
52-Week Price Change -70.91%
50-Day Moving Average 2.06
200-Day Moving Average 5.23
Relative Strength Index (RSI) 48.70
Average Volume (20 Days) 1,017

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.22

Income Statement

In the last 12 months, SLNCF had revenue of 25.83 million and -64.54 million in losses. Loss per share was -1.36.

Revenue25.83M
Gross Profit 23.59M
Operating Income -69.99M
Pretax Income -64.21M
Net Income -64.54M
EBITDA -69.41M
EBIT -69.99M
Loss Per Share -1.36
Full Income Statement

Balance Sheet

The company has 102.19 million in cash and 182,000 in debt, giving a net cash position of 102.01 million.

Cash & Cash Equivalents 102.19M
Total Debt 182,000
Net Cash 102.01M
Net Cash Per Share n/a
Equity (Book Value) 74.06M
Book Value Per Share 1.57
Working Capital 116.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -72.47 million and capital expenditures -117,000, giving a free cash flow of -72.58 million.

Operating Cash Flow -72.47M
Capital Expenditures -117,000
Free Cash Flow -72.58M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 91.32%, with operating and profit margins of -270.95% and -249.86%.

Gross Margin 91.32%
Operating Margin -270.95%
Pretax Margin -248.57%
Profit Margin -249.86%
EBITDA Margin -268.70%
EBIT Margin -270.95%
FCF Margin n/a

Dividends & Yields

SLNCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.98%
Shareholder Yield -7.98%
Earnings Yield -21.65%
FCF Yield -24.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SLNCF has an Altman Z-Score of -3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3
Piotroski F-Score 2